Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: 2016

Transgene presents data on improved cytotoxic activity of oncolytic viruses expressing intrabodies in resistant tumor cell lines

20161005-ov-vancouver-vacv-antibody-poster-final-us

Published 5 October 2016
Categorized as 2016, Press release

Transgene Provides an Update on its Development Strategy and on its First Half-Year 2016 Financials

20160905 – H1 update – EN – V10

Published 5 September 2016
Categorized as 2016, Press release

Transgene Announces Participation at Upcoming Investor Events

20160901 – Next investor events – EN

Published 1 September 2016
Categorized as 2016, Press release

Transgene to Continue Phase 1/1b Study with TG1050 in Chronic Hepatitis B Patients on the Recommendation of the Trial’s Safety Review Committee

20160721 – Safety TG1050 EN Vdef

Published 21 July 2016
Categorized as 2016, Press release, TG1050

Evaluation of a novel oncolytic Raccoonpox virus expressing the bifunctional FCU1 suicide gene

Marine Ricordel, et al. XXI International Poxvirus, Asfavirus and Iridovirus Conference Le Bischenberg (France) 1-5 July 2016 Download the poster here Poster Presentation

Published 1 July 2016
Categorized as -others, 2016, Publication

Improvement of MVA-based Vaccines by Expression of an Autophagy Inhibitor

Anita Spindler, et al. XXI International Poxvirus, Asfavirus and Iridovirus Conference Le Bischenberg (France) 1-5 July 2016 Download the poster here Poster Presentation

Published 1 July 2016
Categorized as -others, 2016, Publication

Oncolytic vaccinia virus TG6002 demonstrates potent efficiency in pancreatic tumor alone and in combination with standard chemotherapies

Johann Foloppe, et al. XXI International Poxvirus, Asfavirus and Iridovirus Conference Le Bischenberg (France) 1-5 July 2016 Download the poster here Poster Presentation

Published 1 July 2016
Categorized as -others, 2016, Publication, TG6002

A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM-CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy

Ghassan K. Abou-Alfa, et al. ASCO Annual Meeting 2016, June 3-7, 2016, Chicago Illinois Download the poster here Poster Presentation

Published 6 June 2016
Categorized as -others, 2016, Pexa-Vec, Publication

Transgene Announces Poster Presentation at ASCO Annual Meeting on the Phase 3 PHOCUS Clinical Trial with Pexa-Vec Oncolytic Immunotherapy

20160531 – ASCO_Poster_PR_V2_clean

Published 31 May 2016
Categorized as 2016, Pexa-Vec, Press release

Composition of the Board of Directors and Statutory Auditors

20160525 – nomination Mr Beret – us

Published 25 May 2016
Categorized as 2016, Press release

Posts pagination

Newer posts Page 1 Page 2 … Page 4 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu